OpenAI CEO Sam Altman said that it was "invigorating" to have new competition in the AI industry with DeepSeek's emergence.

Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.

Tensions between technology leaders Elon Musk and OpenAI CEO Sam Altman were on full display this week after the Tesla CEO ...

It’s the latest clash in a feud between the two tech billionaires that started on OpenAI’s board and is now testing Musk’s ...

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...

Sam’s Club is rolling out major updates, including AI-driven shopping, scan-and-go technology, and more high-end grocery ...

Microsoft-backed OpenAI's chief Sam Altman is planning to visit India next week, three sources with direct knowledge of the ...

The recent surge of the potentially disruptive R1 AI model by Chinese startup DeepSeek is forcing tech leaders from OpenAI, ...

OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company’s first AI agent that can act autonomously on the web. But OpenAI is not Altman ...

DeepSeek has quickly risen to become the most downloaded free app in the US, just one week after its launch. This surge in popularity coincides with growing concerns in the US over a tech race with ...

The Stargate project has big implications for U.S. AI leadership, but also for who's winning the new president's ear.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as ...